Content - Volume 100, January
You can find all new content after October 1 on our new website, you can find it
here.
All articles
SHORT COMMUNICATION
Ryoko Kimura, Nanako Yamada, Yuichi Yoshida, Ayako Ito, Takashi Horie, Kazushi Anzawa, Takashi Mochizuki, Osamu Yamamoto
Abstract is missing (Short communication)
Pages: 1-2
SHORT COMMUNICATION
Kaori Sakaizawa, Atsuko Ashida, Yukiko Kiniwa, Ryuhei Okuyama
Abstract is missing (Short communication)
Pages: 1-2
SHORT COMMUNICATION
Johannes Kjeldstrup Kristensen, Dorthe Grejsen Vestergaard, Carl Swartling, Anette Bygum
Abstract is missing (Short communication)
Pages: 1-2
SHORT COMMUNICATION
Ye Ji Jang, Ji Ha Yoon, Eun Joo Park, Kwang Joong Kim, Kwang Ho Kim
Abstract is missing (Short communication)
Pages: 1-2
SHORT COMMUNICATION
Toshio Ichiki, Kazunari Sugita, Masutaka Furue, Osamu Yamamoto
Abstract is missing (Short communication)
Pages: 1-2
SHORT COMMUNICATION
Rebecca Higgins, Annika N. Jensen, Julian Wachstein, Leena Bruckner-Tuderman, Roland Spiegel, Hubert Traber, Josef Achermann, Martin Schaller, Birgit Fehrenbacher, Martin Röcken, Desislava Ignatova, Yun-Tsan Chang, Tina Fischer, Agnes E. Schwieger-Briel, Lars E. French, Wolfram Hoetzenecker, René Hornung, Andreas Malzacher, Antonio Cozzio, Alexander Navarini, Cristina Has, Emmanuella Guenova
Abstract is missing (Short communication)
Pages: 1-3
INVESTIGATIVE REPORT
Cristina Pellegrini, Ludovica Cardelli, Marina De Padova, Lucia Di Nardo, Valeria Ciciarelli, Tea Rocco, Gianluca Cipolloni, Marco Clementi, Alessio Cortellini, Alessandra Ventura, Pietro Leocata, Maria Concetta Fargnoli
Mutations in MAPK signalling genes are driver events in melanoma, and have therapeutic relevance in the metastatic and adjuvant setting. This study evaluated the intra-patient heterogeneity of BRAF, NRAS and c-KIT mutational status between 30 primary melanomas and 39 related metastases, using molecular analysis and immunohistochemistry. BRAF mutations were identified in 46.7% of primary melanomas ...
Pages: 1-8
SHORT COMMUNICATION
Laurent Misery, Charles Taïeb, Emilie Brenaut, Flavien Huet, Claire Abasq-Thomas, Michèle Sayag, Christine Bodemer
Abstract is missing (Short communication)
Pages: 1-2
SHORT COMMUNICATION
Giuseppe Marangi, Simone Garcovich, Gabriele Di Sante, Daniela Orteschi, Silvia Frangella, Franco Scaldaferri, Maurizio Genuardi, Ketty Peris, Fiorella Gurrieri, Marcella Zollino
Abstract is missing (Short communication)
Pages: 1-2
SHORT COMMUNICATION
Christina Kursewicz, Rodrigo Valdes-Rodriguez, Gil Yosipovitch
Abstract is missing (Short communication)
Pages: 1-2
SHORT COMMUNICATION
Koupaia Legal, Laurent Misery
Abstract is missing (Short communication)
Pages: 1-2
SHORT COMMUNICATION
Mehdi Khallaayoune, Florent Grange, Morgane Condamina, Vanessa Szablewski, Bernard Guillot, Olivier Dereure
Abstract is missing (Short communication)
Pages: 1-2
BOOK REVIEW
Hélène Wolff
Abstract is missing (Book review)
Pages: 1-1
SHORT COMMUNICATION
Anders Nikolai Ørsted Schultz, Peter Jensen, John Robert Zibert, Maria Falck Stigsby, Martin Malmstedt-Miller, Elisabeth B.M. Petersen, Lone Skov, Bjarne Stigsby
Abstract is missing (Short communication)
Pages: 1-2
REVIEW
C. Elise Kleyn, Peter S. Talbot, Nehal N. Mehta, Francesca Sampogna, Chris Bundy, Darren M. Ashcroft, Alexa B. Kimball, Peter C.M. van de Kerkhof, Christopher E.M. Griffiths, Fernando Valenzuela, Joelle M. van der Walt, Tsion Aberra, Lluís Puig
Psoriasis is a systemic, relapsing, inflammatory disease associated with serious comorbidities including mood problems and/or unhealthy lifestyle behaviours. Cutaneous and systemic abnormalities in innate and acquired immunity play a role in its pathogenesis. The exact pathogenetic mechanism remains elusive. Evidence is accumulating that TNF-alpha, IL-17 and IL-23 signalling are highly relevant as ...
Pages: 1-8
SHORT COMMUNICATION
Simone Cazzaniga, Christina Wiedmer, Živa Frangež, Maziar Shafighi, Helmut Beltraminelli, Benedikt Weber, Dagmar Simon, Luigi Naldi, Hans-uwe Simon, Robert E. Hunger, S. Morteza Seyed Jafari
Abstract is missing (Short communication)
Pages: 1-2
SHORT COMMUNICATION
Ellen H.A. van den Munckhof, Tessa Niemeyer-van der Kolk, Hein van der Wall, Dirk C.J.G. van Alewijk, Martijn B.A. van Doorn, Jacobus Burggraaf, Thomas P. Buters, Martin J. Becker, Gary L. Feiss, Wim G.V. Quint, Leen-Jan van Doorn, Cornelis W. Knetsch, Robert Rissmann
Abstract is missing (Short communication)
Pages: 1-2
INVESTIGATIVE REPORT
Ulrike Wehkamp, Marion Jost, Kai Wehkamp, Jürgen Harder
Mycosis fungoides and Sézary syndrome belong to the group of primary cutaneous T-cell lymphomas. Because of the inflammatory appearance of the skin lesions, we hypothesized that antimicrobial peptides might be dysregulated in these conditions, similar to in inflammatory skin conditions. Samples from 20 patients with cutaneous T-cell lymphoma were analysed using immunohistochemistry and enzyme-lin ...
Pages: 1-6
SHORT COMMUNICATION
Giulia Gasparini, Giulia Ciccarese, Emanuele Cozzani, William Bruno, Francesco Cabiddu, Margherita Cioni, Michele Paudice, Aurora Parodi
Abstract is missing (Short communication)
Pages: 1-2
SPECIAL REPORT
Jacob P. Thyssen, Teresa Berents, Maria Bradley, Mette Deleuran, Øystein Grimstad, Laura Korhonen, Tor Langeland, Tore Särnhult, Simon Francis Thomsen, Turid Thune, Carl-Fredrik Wahlgren, Christian Vestergaard, Laura B. von Kobyletzki, Anita Remitz
Similarities and differences in the everyday clinical management of moderate-to-severe atopic dermatitis in Nordic countries are unknown. Using a modified Delphi approach, 15 dermatologists from Denmark, Finland, Norway and Sweden completed face-to-face and online questionnaires and participated in summary discussions to map expert opinion on the clinical management of moderate-to-severe atopic de ...
Pages: 1-11
SHORT COMMUNICATION
Adrien Mareschal, Eve Puzenat, François Aubin
Abstract is missing (Short communication)
Pages: 1-2
CLINICAL REPORT
Andrew Maguire, Jorge Puelles, Patrick Raboisson, Rajeev Chavda, Sylvie Gabriel, Susan Thornton
Most patients with mycosis fungoides are diagnosed with early-stage disease. However, prevalence of early-stage disease is unknown, and evidence of its burden is scarce. The aim of this study is to estimate the prevalence of early-stage mycosis fungoides, how long patients live with early-stage disease and to characterise these patients. Data were obtained from 4 key publications and from US cance ...
Pages: 1-6
REVIEW
Anders Würgler Hansen, Zahràa Chayed, Kristine Pallesen, Ileana Codruta Vasilescu, Anette Bygum
Hereditary leiomyomatosis and renal cell cancer is a genodermatosis with an autosomal dominant inheritance pattern. It is a tumour predisposition syndrome characterized by cutaneous and uterine leiomyomas, and increased susceptibility to develop renal cell carcinoma. There are 200–300 families with hereditary leiomyomatosis and renal cell carcinoma reported worldwide, but the syndrome is believe ...
Pages: 1-7
QUIZ
Victor Olsavszky, Cyrill Géraud
Abstract is missing (Quiz)
Pages: 1-3
INVESTIGATIVE REPORT
Åsa M. C. Ingvar, Håkan Olsson, Per Broberg, Karolin Isaksson, Christian Ingvar, Kari Nielsen
Prospective observational studies have shown previously that study participants have lower morbidity and mortality than non-participants. The aim of the current study was to determine whether participants in a prospective cohort study on melanoma have a different incidence and mortality of melanoma compared with non-participants and the background population. Information was collected from Swedish ...
Pages: 1-6
CLINICAL REPORT
Christian Drerup, Maria Eveslage, Cord Sunderkötter, Jan Ehrchen
Clinical differentiation between herpes zoster and bacterial superficial skin and soft tissue infections of the face can be difficult. In addition, diagnosis can be complicated by bacterial superinfection of lesional herpes zoster. The aim of this study was to determine whether inflammatory parameters, such as C-reactive protein (CRP) and blood counts, might be reliable biomarkers to distinguish b ...
Pages: 1-5
INVESTIGATIVE REPORT
Katrine Baumann, Sidsel Falkencrone, Niels Peter Hell Knudsen, Anders Woetmann, Sally Dabelsteen, Per Stahl Skov
Microdialysis is a well-established technique for sampling of small molecules from the human skin, but larger molecules are more difficult to recover. Consequently, sampling feasibility must be evaluated before microdialysis is used in vivo. This report presents a tool for estimating the recovery of large biomarkers from human skin by microdialysis, using previously frozen human skin specimens as ...
Pages: 1-8
SHORT COMMUNICATION
Florentia Dimitriou, Joanna Mangana, Reinhard Dummer
Abstract is missing (Short communication)
Pages: 1-2
CLINICAL REPORT
Lyn Guenther, Alison Potts Bleakman, Jamie Weisman, Yves Poulin, Lynda Spelman, Russel Burge, Janelle Erickson, Kristin Todd, Clinton C. Bertram, Caitriona Ryan
Ixekizumab was efficacious in treating moderate-to-severe genital psoriasis over 12 weeks. We evaluated the long-term efficacy and safety of ixekizumab for up to 52 weeks. Patients were randomized to 80 mg ixekizumab every 2 weeks or to placebo through Week 12, then received 80 mg open-label ixekizumab every 4 weeks through Week 52. In patients initially randomized to ixekizumab, clear or almost c ...
Pages: 1-9
REVIEW
Christoffer Aam Ingvaldsen, Truls Michael Leegaard, Gunnhild Kravdal, Cato Mørk
Infectious pseudochromhidrosis is a rare dermatological disorder, characterized by a change in colour of the sweat from normal skin, caused by pigments from microorganisms. Such pigments are a result of evolutionary competition among microorganisms, which appears to be a decisive factor in their survival, pathogenicity, and virulence. Four bacteria are known to be involved in infectious pseudoch ...
Pages: 1-7
QUIZ
Iwona Chlebicka, Aleksandra Stefaniak, Karolina Wójcicka, Jacek C. Szepietowski
Abstract is missing (Quiz)
Pages: 1-2
SHORT COMMUNICATION
Alessandra Buja, Michele Rivera, Manuel Zorzi, Milena Sperotto, Susanna Baracco, Irene Italiano, Antonella Vecchiato, Paolo Del Fiore, Francesco Avossa, Maria Chiara Corti, Stefano Guzzinati, Mario Saia, Vincenzo Baldo, Massimo Rugge, Carlo Riccardo Rossi
Abstract is missing (Short communication)
Pages: 1-2
SHORT COMMUNICATION
Kira Süßmuth, Dieter Metze, Ana-Maria Muresan, Kai Lehmberg, Udo zur Stadt, Carsten Speckmann, Julien Heinrich Park, Thorsten Marquardt, Vinzenz Oji, Tobias Goerge
Abstract is missing (Short communication)
Pages: 1-2
CLINICAL REPORT
Alice Ramondetta, Simone Ribero, Luca Conti, Paolo Fava, Elena Marra, Paolo Broganelli, Virginia Caliendo, Franco Picciotto, Michele Guida, Maria Teresa Fierro, Pietro Quaglino
Current therapies for metastatic melanoma (anti-PD1 and BRAF/MEK inhibitors) can cause drug-induced vitiligo. The aim of this study is to dermatologically define and histologically characterize this new type of vitiligo, and assess the clinical course of the disease. Fourteen patients with metastatic melanoma treated with immune or targeted therapy were included in a dataset evaluating clinical da ...
Pages: 1-5